Clinical trial
Infliximab to Treat Non-Infectious Scleritis
NCT00075075 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00075075 |
|---|---|
| Title | Infliximab to Treat Non-Infectious Scleritis |
| Official title | Pilot Study of the Evaluation of Infliximab in the Treatment of Non-Infectious Scleritis |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Scleritis |
| Intervention type | Drug |
| Interventions | Infliximab |
| Enrollment | 5 |
| Start date | Dec 23, 2003 |
| Completion | Sep 6, 2007 |
| First posted | Jan 1, 2004 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: